| | | Single nucleotide variant (nonsense) | not provided | |
| | | Insertion (frameshift variant) | not provided | |
| | | Deletion (frameshift variant) | not provided | |
| | | Single nucleotide variant (splice donor variant) | not provided | |
| | | Single nucleotide variant (nonsense) | Immunoglobulin-mediated membranoproliferative glomerulonephritis +1 more | |
| | | Single nucleotide variant (nonsense) | not provided | |
| | | Duplication (frameshift variant) | Immunoglobulin-mediated membranoproliferative glomerulonephritis +2 more | |
| | | Single nucleotide variant (missense variant) | Familial hyperaldosteronism type II | |
| | | Single nucleotide variant (nonsense) | Familial hyperaldosteronism type II | |
| | | Single nucleotide variant (missense variant) | Familial hyperaldosteronism type II | |
| | | Single nucleotide variant (missense variant) | Familial hyperaldosteronism type II | |
| | | Single nucleotide variant (missense variant) | Leukoencephalopathy with mild cerebellar ataxia and white matter edema +2 more | |
| | | Single nucleotide variant (nonsense) | Immunoglobulin-mediated membranoproliferative glomerulonephritis +2 more | |
| | | Duplication (frameshift variant) | Atypical hemolytic-uremic syndrome +1 more | GLikely pathogenic; risk factor |
| | | Single nucleotide variant (missense variant) | AHUS, SUSCEPTIBILITY TO, 7 +1 more | GLikely pathogenic; risk factor |
| | | Single nucleotide variant (nonsense) | AHUS, SUSCEPTIBILITY TO, 7 +1 more | GLikely pathogenic; risk factor |
| | | Single nucleotide variant (missense variant) | AHUS, SUSCEPTIBILITY TO, 7 | |